Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency
- PMID: 11508546
- DOI: 10.1055/s-2000-12944
Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency
Abstract
White matter abnormalities are a feature of many inborn errors of metabolism and magnetic resonance imaging (MRI) of the brain has become an important tool in the diagnostic work-up of these disorders. Recently, patients were reported with a potentially treatable disorder of serine biosynthesis. They presented with congenital microcephaly, severe psychomotor retardation and intractable seizures. Low concentrations of the amino acids serine, glycine as well as 5-methyltetrahydrofolate were found in plasma and CSF and were due to a deficiency of the enzyme 3-phosphoglycerate dehydrogenase (3-PGDH). We studied four patients aged 10 months to 7 years by MRI before and after treatment with amino acids with a follow-up of 16 months to 6 years. Magnetic resonance spectroscopy (MRS) was performed in two patients at 4 and 16 months of treatment. Pre-treatment MRI demonstrated hypomyelination and profound white matter attenuation in all patients. During treatment, a significant increase in white matter volume was found and a progress of myelination in two patients. The most striking finding on MRS during treatment was an elevated level of white matter choline. Serine biosynthesis defects have to be considered in the differential diagnosis of patients with mental retardation, microcephaly, seizures, and on MRI hypomyelination and white matter attenuation.
Similar articles
-
Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings.Neuropediatrics. 2001 Aug;32(4):191-5. doi: 10.1055/s-2001-17373. Neuropediatrics. 2001. PMID: 11571699
-
3-phosphoglycerate dehydrogenase deficiency: a case report of a treatable cause of seizures.Turk J Pediatr. 2009 Nov-Dec;51(6):587-92. Turk J Pediatr. 2009. PMID: 20196394
-
Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency.Ann Neurol. 1998 Aug;44(2):261-5. doi: 10.1002/ana.410440219. Ann Neurol. 1998. PMID: 9708551
-
Continuing education in neurometabolic disorders--serine deficiency disorders.Neuropediatrics. 1999 Feb;30(1):1-4. doi: 10.1055/s-2007-973447. Neuropediatrics. 1999. PMID: 10222452 Review.
-
3-Phosphoglycerate dehydrogenase deficiency: description of two new cases in Tunisia and review of the literature.Neuropediatrics. 2013 Oct;44(5):281-5. doi: 10.1055/s-0033-1338133. Epub 2013 Apr 6. Neuropediatrics. 2013. PMID: 23564319 Review.
Cited by
-
Fatal cerebral edema associated with serine deficiency in CSF.J Inherit Metab Dis. 2010 Dec;33 Suppl 3(Suppl 3):S181-5. doi: 10.1007/s10545-010-9067-9. Epub 2010 Mar 19. J Inherit Metab Dis. 2010. PMID: 20300853 Free PMC article.
-
On the phenotypic spectrum of serine biosynthesis defects.J Inherit Metab Dis. 2016 May;39(3):373-381. doi: 10.1007/s10545-016-9921-5. Epub 2016 Mar 10. J Inherit Metab Dis. 2016. PMID: 26960553
-
Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids.J Inherit Metab Dis. 2002 May;25(2):119-25. doi: 10.1023/a:1015624726822. J Inherit Metab Dis. 2002. PMID: 12118526
-
An update on serine deficiency disorders.J Inherit Metab Dis. 2013 Jul;36(4):613-9. doi: 10.1007/s10545-013-9592-4. Epub 2013 Mar 6. J Inherit Metab Dis. 2013. PMID: 23463425
-
L-serine in disease and development.Biochem J. 2003 May 1;371(Pt 3):653-61. doi: 10.1042/BJ20021785. Biochem J. 2003. PMID: 12534373 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous